Fagiolini, A. et al. 2011. Pharmacoeconomic comparison of ziprasidone with other atypical oral antipsychotic agents in schizophrenia. Farmeconomia. Health economics and therapeutic pathways. 12, 1 (Nov. 2011), 29–40. DOI:https://doi.org/10.7175/fe.v12i1.96.